louisiana glp-1 pancreatitis law firm Novo Nordisk is suing Eli Lilly over its ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro and Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW ⬇️ glp-1 pancreatitis lawyer in louisiana

In this experiment, cages were modified to facilitate the use of the DietMax food monitor system for continuous recording of powdered kaolin consumption

In a 4-week controlled trial of VYVANSE in pediatric patients ages 13 to 17 years, mean weight loss from baseline to endpoint was -2.7, -4.3, and -4.8 lbs., respectively, for patients receiving 30 mg, 50 mg, and 70 mg of VYVANSE, compared to a 2.0 pound weight gain for patients receiving placebo

Publix said its registered dietitian nutritionists use current scientific research, including the USDA Dietary Guidelines for Americans, to compare similar products

Karen Basbaum, Chief Business Officer Number Of Employees: ~63 Stage: Publicly traded Financial Snapshot: The market cap for July 2026 is $2.81 billion